Atlas Trials

Observational Study of ASCVD Risks of Type 2 Diabetes in East China

Clinical trial NCT04866667 · COMPLETED

Trial details

NCT number
NCT04866667
Sponsor
Zhejiang Provincial People's Hospital
Status
COMPLETED
Study type
OBSERVATIONAL
Type 2 Diabetes MellitusArteriosclerotic Cardiovascular DiseaseLiraglutide
Start date
2021-05-01
Primary completion
2023-12-31
Enrollment
316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.